Looking Ahead: What’s New In CAR T-Cell Therapy for Hematologic Malignancies – Curetoday.com
Curetoday.com |
Looking Ahead: What's New In CAR T-Cell Therapy for Hematologic Malignancies
Curetoday.com The building blocks of this therapy are T cells which are collected and then altered to produce chimeric antigen receptors or CARs. These CAR T cells are then infused into the patient to multiply, recognize cancer cells and kill those cancer cells that … |
